LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 31 of 497
Next
>>
>
751 to 775 of 12420 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Relative Growth Rate After Treatment
BT-20	A443654	0.37	uM	LJP6	1	I22	72	hr	1657	1569	5505	0.2850	-0.0231
BT-20	A443654	0.37	uM	LJP6	2	I22	72	hr	1657	1454	5505	0.2641	-0.0529
BT-20	A443654	0.37	uM	LJP6	3	I22	72	hr	1657	1463	5505	0.2657	-0.0506
BT-20	OSI-027	0.37	uM	LJP6	1	E10	72	hr	1657	3033	5505	0.5509	0.3574
BT-20	OSI-027	0.37	uM	LJP6	2	E10	72	hr	1657	3405	5505	0.6185	0.4541
BT-20	OSI-027	0.37	uM	LJP6	3	E10	72	hr	1657	3902	5505	0.7087	0.5832
BT-20	XMD11-85h	0.37	uM	LJP6	1	P22	72	hr	1657	5095	5505	0.9254	0.8933
BT-20	XMD11-85h	0.37	uM	LJP6	2	P22	72	hr	1657	5135	5505	0.9327	0.9037
BT-20	XMD11-85h	0.37	uM	LJP6	3	P22	72	hr	1657	5457	5505	0.9912	0.9874
BT-20	HG-6-64-01	0.37	uM	LJP6	1	M04	72	hr	1657	4342	5505	0.7886	0.6976
BT-20	HG-6-64-01	0.37	uM	LJP6	2	M04	72	hr	1657	4746	5505	0.8620	0.8026
BT-20	HG-6-64-01	0.37	uM	LJP6	3	M04	72	hr	1657	4788	5505	0.8697	0.8135
BT-20	WH-4-025	0.37	uM	LJP5	1	O10	72	hr	1657	3148	5505	0.5718	0.3873
BT-20	WH-4-025	0.37	uM	LJP5	2	O10	72	hr	1657	4067	5505	0.7387	0.6261
BT-20	WH-4-025	0.37	uM	LJP5	3	O10	72	hr	1657	3566	5505	0.6477	0.4959
BT-20	WZ-4-145	0.37	uM	LJP6	1	J22	72	hr	1657	4640	5505	0.8428	0.7750
BT-20	WZ-4-145	0.37	uM	LJP6	2	J22	72	hr	1657	4954	5505	0.8998	0.8566
BT-20	WZ-4-145	0.37	uM	LJP6	3	J22	72	hr	1657	4364	5505	0.7926	0.7033
BT-20	XMD16-144	0.37	uM	LJP5	1	M10	72	hr	1657	2030	5505	0.3687	0.0967
BT-20	XMD16-144	0.37	uM	LJP5	2	M10	72	hr	1657	2253	5505	0.4092	0.1547
BT-20	XMD16-144	0.37	uM	LJP5	3	M10	72	hr	1657	2149	5505	0.3903	0.1277
BT-20	Brivanib	0.37	uM	LJP5	1	P16	72	hr	1657	5140	5505	0.9336	0.9050
BT-20	Brivanib	0.37	uM	LJP5	2	P16	72	hr	1657	5316	5505	0.9656	0.9507
BT-20	Brivanib	0.37	uM	LJP5	3	P16	72	hr	1657	5485	5505	0.9963	0.9946
BT-20	Buparlisib	0.37	uM	LJP5	1	H04	72	hr	1657	3557	5505	0.6461	0.4936

|<
<<
Previous
Page 31 of 497
Next
>>
>
751 to 775 of 12420 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)